Search Results 21-30 of 69 for ❌도우미급9:OIO

  1. https://www.mayoclinic.org/organization_concepts.xml

  2. https://www.mayoclinic.org/procedure_concepts.xml

  3. https://www.mayoclinic.org/~/media/FD382661FD544C6CB4A38FC785855FAB

  4. Tucatinib, Trastuzumab, Ramucirumab, and Paclitaxel Versus Paclitaxel and Ramucirumab in Previously Treated HER2+ Gastroesophageal Cancer - Mayo Clinic

    This is an international, multicenter Phase 2/3 study in subjects with locally-advanced unresectable or metastatic HER2+ GEC who have received prior treatment ...

  5. A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma - Mayo Clinic

    The purpose of this study is to define the recommended dose, safety, tolerability, immunogenicity, and preliminary effectiveness of EO2463 during monotherapy ...

  6. Safety and Preliminary Efficacy of OBT076 in Recurrent/​Metastatic CD205+ Solid Tumors - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  7. A Study to Evaluate Tazemetostat Combined with Lenalidomide Plus Rituximab in Subjects With Relapsed/Refractory Follicular Lymphoma - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness and safety of tazemetostat in combination with R2 in subjects with Relapsed/Refractory Follicular ...

  8. A Study to Evaluate the Combination of Binimetinib and Palbociclib in Treating Patients with KRAS and NRAS Mutant Metastatic or Unresectable Colorectal Cancer - Mayo Clinic

    Binimetinib and palbociclib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as TAS- ...

  9. A Phase 3, placebo-controlled study to investigate LP352 in children and adults with Dravet Syndrome - Mayo Clinic

    The purpose of this study is to determining efficacy of LP352-302 in treating Dravet Syndrome among pediatric and adult populations. Participation eligibility.

  10. Publications - Jithma P. Abeykoon, M.D. - Mayo Clinic

    2024 Sep 1; 109 (9):2884-2892 Epub 2024 Sept 01. View PubMed; Zanwar S, Le-Rademacher J, Durot E, D'Sa S, Abeykoon JP, Mondello P, Kumar S, Sarosiek S, Paludo ...